From: Plasma exosome-derived connexin43 as a promising biomarker for melanoma patients
Variable | prognostic value (n = 112) |
---|---|
5-year DFS | |
AUROC | 0.78(95% CI: 0.70–0.86) |
Cutoff value (95%CI) | 0.69 |
Sensitivity, % | 81.55(95% CI: 72.70–88.50) |
Specificity, % | 77.78(95% CI: 40.00-97.20) |
Positive predictive value, % | 97.70(95% CI: 91.90–99.70) |
Negative predictive value, % | 26.90(95% CI: 11.60–47.80) |
Positive likelihood ratio | 3.67(95% CI: 1.10–12.50) |
Negative likelihood ratio | 0.24(95% CI: 0.10–0.40) |
5-year OS | |
AUROC | 0.77(95% CI: 0.68–0.84) |
Cutoff value (95%CI) | 0.67 |
Sensitivity, % | 65.98(95% CI: 55.70–75.30) |
Specificity, % | 80.00(95% CI: 51.90–95.70) |
Positive predictive value, % | 95.50(95% CI: 87.50–99.10) |
Negative predictive value, % | 26.70(95% CI: 14.60–41.90) |
Positive likelihood ratio | 3.30(95% CI: 1.20–9.20) |
Negative likelihood ratio | 0.43(95% CI: 0.30–0.60) |